The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-α treatment

Cancer Letters

Volumn 68, Issue 1, 1993, Pages 25-31

  Richters, C D ^a   Burger, C W ^a   van de Loosdrecht, A A ^a   van Rijswijk, R E N ^a,b   Calame, W ^a   Bleker, O P ^c   Vermorken, J B ^a,b   Kenemans, P ^a   Beelen, R H J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Department of Cell Biology Free University Hospital ^*  (Netherlands)

Author keywords

cytotoxicity; epithelial ovarian cancer; human macrophages; tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; CELL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; OVARY CANCER; PERITONEAL CAVITY; PERITONEUM CELL; PRIORITY JOURNAL; TUMOR CELL DESTRUCTION;

ADENOCARCINOMA; ADULT; AGED; CASE REPORT; CELL COUNT; CYSTADENOCARCINOMA; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMAN; IMMUNOPHENOTYPING; MACROPHAGES; MIDDLE AGE; OVARIAN NEOPLASMS; PERITONEAL CAVITY; TUMOR NECROSIS FACTOR;

EID: 0027452609     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(93)90215-U     Document Type: Article

References (20)

1. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation
2. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy
3. Distinct subpopulations of elicited human macrophages in peritoneal dialysis and women undergoing laparoscopy: a study on peroxidatic activity
4. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence
5. Anti-tumor and immunomodulatory activity of intraperitoneal IFN-γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy
6. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small cell lung cancer: toxicity and immunomodulatory effects
7. Macrophages and metastasis — a biological approach to cancer therapy: Presidential address
8. Seperate ontogeny of two macrophage-like accesory cell populations in the human fetus
9. Monoclonal antibody EBM 11: high cellular specificity for human macrophages
10. Impaired monocyte-macrophage cytotoxity in patients with Hodgkin's disease
11. Role of interferon-γ and tumor necrosis factor-α in monocyte mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line
12. Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study
13. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, IFN-γ and interleukin-1
14. Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites
15. Biological and clinical effects of intravenous tumour necrosis factor-α administered three times weekly
16. Recombinant human tumour necrosis factor administered as a 24-hour intravenous infusion
17. Fate of γ-interferon activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis
18. Tumour necrosis factor: A potent effector for tumour cell killing by activated macrophages